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Head and neck squamous cell carcinomas (HNSCC) 
comprise about 6% of all malignant neoplasms. Overall 
survival is low, especially in developing countries, and 
the major risk factors of HNSCC are smoking and/or al-
cohol consumption [1]. Tobacco and alcohol consump-
tion are the main etiological factors in head and neck 
carcinogenesis [2]. Head and neck carcinogenesis is 
associated with abnormalities in DNA repair, apoptosis, 
carcinogen metabolism and cell-cycle control [3–5].
Polymorphisms of DNA repair genes may influence 
variation in individual DNA repair capacity, which is 
crucial for preventing genomic instability and in turn 
may be associated with risk of cancer [6]. Among the 
various DNA repair pathways, base excision repair 
(BER) is considered to play a key role by removing 
DNA damage from oxidation, deamination, and ring 
fragmentation [7]. Exposure to tobacco smoking 
can increase production of reactive oxygen species 
(ROS), which have the potential to induce oxidative 
damage, like the stable guanine adduct 8-oxoguanine 
[8]. Moreover, the variation in ability of glycosylases 
MUTYH or OGG1 involving in BER may be associated 
with cancer risk occurrence [9]. MUTYH excises the 
misincorporated adenine opposite 8-oxoguanine, and 
thus prevents 8-oxoguanine-induced mutagenesis. 
An increased susceptibility to spontaneous carcino-
genesis of the liver, lung or intestine was observed in 
MUTYH-null mice [10]. Moreover Germ-line MUTYH 
mutations predispose persons to a recessive pheno-
type, multiple adenomas, or polyposis coli [11].
In this paper we described a case-control study 
performed to test the association between single 
nucleotide polymorphisms (SNPs) of MUTYH gene 
and the occcurence as wel as progression of head and 
neck cancer. We investigated MUTYH polymorphism 
of a G → A transition producing a Tyr → Cys substitution 
at codon 165 located in chromosome 1 (the Tyr165Cys 
polymorphism; rs34612342) in patients with precancer-
ous hyperplastic laryngeal lesions (PHLL), patients with 
head and neck cancer and cancer-free controls.
Patients. Blood samples were obtained from 193 pa-
tients, among them 97 subjects had precancerous hyper-
plastic laryngeal lesions (80 men and 17 women; median 
age 52, quartiles: 37, 74 years) and 96 subjects have 
been diagnosed with head and neck cancer (83 men 
and 13 women; median age 54, quartiles: 37, 76 years). 
Control samples consisted of age- (± 5 years) and sex-
matched 140 cancer-free blood donors. The diagnosis 
of cancer was made after histopathological examina-
tion of patients biopsies. Patients with precancerous 
hyperplastic laryngeal lesions were selected during 
direct laryngoscopy with the minimal clinical follow-up 
10 years. Patients and controls subjects enrolled to the 
examination were also matched in smoking attitude or 
alcohol consumption. Prior to examination, the patients 
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and control subjects, did not receive medicaments like 
antibiotics or steroids. All patients and controls subjects 
were recruited from three medical units of Head and Neck 
Neoplasm Surgery Departments, Medical University of 
Lodz, Poland. All subjects included into the study were 
unrelated Caucasians and inhibited Lodz district, Poland. 
The study was approved by the Local Ethic Committee 
and written consent was obtained from each patient or 
healthy blood donor before enrolling into the study.
Chemicals and reagents. QIAamp DNA Blood 
Mini Kit for isolation of high-molecular-weight DNA 
was obtained from Qiagen (Chatsworth, CA, USA). All 
reagents for PCR reaction were from Qiagen. Elektro-
phoresis was conducted in TAE buffer.
Genotyping. Genomic DNA was prepared using the 
QIAamp DNA Blood Mini Kit for isolation of high-mole-
cular-weight DNA. Multiplex Tetra-Primer Amplification 
Refractory Mutation System PCR was used to detect 
the genotypes of the Tyr165Cys polymorphism of the 
MUTYH gene associated with head and neck cancer. 
T-ARMS-PCR amplified both wild-type and mutant al-
leles, together with a control fragment, in a single tube 
PCR reaction. The region flanking the mutation was am-
plified by 2 common (outer) primers, producing a non–
allele-specific control amplicon 200 bp in length:
Fo 5’GGGACTGACGGGTGATCTCTTTGACCTCTG 3’
Ro 5’CCTCTACCACCTGATTGGAGTGCAAGACTC 3’
Two allele-specific (inner) primers:
Fi(G) 5’GGTGAATCAACTCTGGGCTGGCCTGGGATG 3’ 
Ri(A) 5’CTGCAGCCGCCGGCCACGAGAATCGT 3’
were designed in opposite orientation and, in combina-
tion with the common primers, simultaneously amplified 
both the wild-type and the mutant amplicons 100 bp 
and 155 bp in length respectively. PCR primers and 
conditions for amplification was described previously by 
Piccili et al. [12]. The 2 allele-specific amplicons have 
different lengths were separated by 8% polyacrylamide 
gel electrophoresis. More than 10% of the samples were 
repeated, and the results were 100% concordant.
Data analysis. Distribution of genotypes and alleles 
between groups were tested using chi-square tests. Poten-
tial linkage between genotype and cancer was assessed 
by the logistic regression. Analyses were performed us-
ing STATISTICA 6.0 package (Statsoft, Tulsa, OK, USA). 
The genotypes of patients and controls were 
scored according to Tyr165Cys polymorphism of 
MUTYH gene (Figure). All distributions did not dif-
fer significantly (P > 0.005) from those predicted by 
the Hardy-Weinberg equilibrium. An statistically sig-
nificant association between head and neck cancer 
occurrence and the Tyr165Tyr genotype was found 
(OR 2.18; 95% CI 1.19–3.97) (Table 1). Additionally, 
there were statistically significant differences in the 
frequency of Tyr165 allele between HNSCC patients and 
controls (OR 1.81; 95% CI 1.05–3.13), while there were 
not observed any differences in the frequency of the 
Cys165 allele (see Table 1). Finally, we did not observe 
any correlation between Tyr165Cys polymorphism of 
MUTYH gene and precancerous hyperplastic laryngeal 
lesions risk.
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Figure. Representative T-ARMS-PCR for the Tyr165Cys  polymor-
phism of MUTYH gene. Lane M, DNA marker 100 bp; lanes: 1, 2, 5, 
7 wild-type control 100 bp band; lanes: 3, 4 Tyr165Cys heterozy-
gote; 100 and 155 bp bands and lane: 6 Cys165Cys homozygote 
155 bp band. In each line 200 bp product indicate a positive 
control of PCR. T-ARMS-PCR products were electrophoresed on 
a 8% polyacrylamide gel containing ethidium bromide. MUTYH 
T-ARMS-PCR band sizes are indicated on the right of panel
Table 2 shows the distribution of genotypes and 
frequency of alleles in groups of patients suffer head 
and neck cancer with different tumour size (T) and node 
status (N). We found statistically significant differences 
in distribution of the Tyr165Tyr genotype (OR 4.56; 95% 
CI 1.60–12.95) and frequency of Tyr156 allele (OR 17.39; 
95% CI 7.10–42.59) in group of patients with different 
tumour size, when patients with T3 and T4 grades were 
compared with patients with T1 and T2 grade. Addition-
ally, there was no differences in the distribution of geno-
types and frequency of alleles in patients with positive 
(N1 + N2 + N3 + N4) and negative (N0) lymph node.
Table 1. The genotype and allele frequency and odds ratio (OR) of the Tyr165Cys polymorphism of the MUTYH gene in head and neck cancer (HNSCC) 
and precancerous hyperplastic laryngeal lesions (PHLL)
HNSCC (n = 96) Controls (n = 140) PHLL (n = 97)
Genotype or Allele Fre quen cy Fre quen cy OR (95% CI) Frequency OR (95% CI)
Tyr165Tyr 0.80 0.64 2.18 (1.19–3.97) 0.53 0.66 (0.39–1.12)
Tyr165Cys 0.19 0.36 0.43 (0.23–0.79) 0.43 1.28 (0.75–2.17)
Cys165Cys 0.01 – – 0.04 –
165Tyr 0.90 0.82 1.81 (1.05–3.13) 0.74 0.66 (0.42–1.03)
165Cys 0.10 0.18 0.55 (0.32–0.95) 0.26 1.51 (0.97–2,36)
Notes: “CI” – confidence interval; “–” – not estimated.
Table 2. The genotype and allele frequency and odds ratios (OR) of the Tyr165Cys polymorphism of MUTYH gene in patients with head and neck cancer 
with different tumor size and lymph node status
Tumour size Node status
Geno type or Allele T3 + T4 Fre quen cy T1+ T2 Fre quen cy OR (95% CI) N1 + N2 + N3 + N4 Fre quen cy N0 Fre quen cy OR (95% CI)
Tyr/Tyr 0.89 0.63 4.56 (1.60–12.95) 0.81 0.78 1.14 (0.41–3.21)
Tyr/Cys 0.11 0.34 0.25 (0.09–0.71) 0.19 0.20 0.96 (0.34–2.73)
Cys/Cys – 0.03 – – 0.02 –
Tyr 0.94 0.80 17.39 (7.10–42.59) 0.90 0.88 1.23 (0.47–3.20)
Cys 0.06 0.20 0.06 (0.02–0.14) 0.10 0.12 0.82 (0.31–2.13)
Notes: “CI” – confidence interval; “–” – not estimated.
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An association between the risk of occurrence 
and progression of the head and neck cancer and 
the Tyr165Cys polymorphism of the MUTYH gene of 
BER-repair DNA pathway has not been investigated 
previously. Our results suggest that this polymorphism 
may increase the risk of head and neck cancer in Polish 
population (OR 2.18 for homozygous Tyr165Tyr). We 
also found an association between Tyr165Tyr genotype 
of MUTYH gene and head and neck cancer progression 
assessed by tumour size (OR 4.56). However, we did 
not observe any correlation between Tyr165Cys poly-
morphism of MUTYH gene and precancerous hyper-
plastic laryngeal lesions risk. Thus, this polymorphism 
may not reflect the progression of PHLL as it is allowed 
to be determined by classic histological grading.
There is only a few data reported an investigation of 
MUTYH gene polymorphisms in association with cancer 
occurrence. Previously, it was found that recessive muta-
tions of the MUTYH gene predispose to multiple colorec-
tal adenomas and carcinoma [13–18]. Other reports have 
suggested that the Gln324His variant of MUTYH gene is 
strongly associated with colorectal cancer in Japanese 
population [19, 20]. In contrast, Gorgens et al. have not 
found any correlation between polymorphisms of MUTYH 
gene and the etiology of a head and neck cancer [21], but 
they investigated Val22Met, Gln324His and Val315Met 
variants and they did not investigated Tyr165Cys. The 
other reason that no correlation was found by Gorgens et 
al. might be extremely small number of subjects enrolled 
to their study (29 patients and 30 controls). In our study 
we investigated an association of Tyr165Cys polymor-
phism of MUTYH gene in group of 193 patients (among 
them 97 subjects with precancerous hyperplastic laryn-
geal lesions and 96 subjects with head and neck cancer) 
and 140 cancer-free controls. Our study is the first that 
reported an assaociation of Tyr165Tyr polymorphic vari-
ant of MUTYH gene with head and neck cancer.
Evidences consistently linking SNPs in the DNA repair 
genes with pathogenesis of head and neck cancer are 
still limited. In the post-genomic era we think about or-
chestration of the expression of the genome rather, than 
about acts of expression of individual genes. However, to 
construct a reliable microarray dedicated to any cancer 
a large set of SNPs data should be obtained. We suggest 
that the Tyr165Cys polymorphism of the MUTYH gene may 
be considered as an early diagnostic marker in occurrence 
and progression of the head and neck cancer.
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